Client References
Examples of challenges that Bioneer has solved for clients and collaborators
Using our Drug Development Services Bioneer:FARMA:
- has assisted Roche on dissolution studies using Bioneer:FARMA’s proprietary bio-simulated medias and lipolysis models
- has assisted Novozymes in structural analysis of biomacromolecules
- has, using Caco-2 models, investigated pharmacological properties of Santaris Pharma 's LNA platform
- has assisted LEO Pharma regarding permeability studies of drug candidates
- Bioneer:FARMA has assisted IPC-Pharma with dissolution studies of compounds under development
- DSM has used Bioneer:FARMA's expertise on in-vitro lipolysis modeling
- has helped Tectra (Region Hovedstadens Tech Trans Enhed) with synthesis of small molecules for pharmaceutical testing
- Bioneer:FARMA has assisted LiPlasome Pharma with access to equipment
- Coloplast has used Bioneer:FARMA’s expertise within formulation development
- assisted Sanos Bioscience in physiochemical characterization of peptide formulations
- Bioneer:FARMA has developed formulations for in vivo studies for MycoTeQ
- has assisted NeuroKey with development and characterization of compound formulations for animal studies
- has assisted Pronova on development and characterization of Pronova´s products
Using our Protein Manufacturing Services Bioneer:
- Bioneer has for more than a decade been world-wide provider of the enzyme Benzonase, a DNAse produced for - and distributed by - Merck KGaA. The Benzonase is produced under near-GMP conditions and has multiple uses in pharmaceutical products globally
- Bioneer has assisted Orphazyme with the manufacturing of recombinant protein for preclinical studies
- Bioneer is assisting ALK with the establishment of recombinant production of cat allergens
- developed and established a production process for a biologics drug candidate for a biotech company using our proprietary L. lactis P170 production system
- established production strains for a novel enzyme for Agazyme
- Bioneer has provided services to support Symphogen's recombinant antibody discovery activities
- Bioneer has collaborated with PX-Therapeutics regarding recombinant protein production
Using our Immune Targeting Services Bioneer:
- applied the dendritic cell and PBMC model for immunological studies of LNA-based drug candidates of Santaris Pharma
- analysed probiotics for their effects using our in vitro probiotics screening technologies and our murine and human dendritic cell models
- has used our dendritic cell models to assist Novozymes
- has assisted TeLoRmedix on compound profiling used our dendritic cell models
Using our Expertices within Biology Bioneer:
- has assisted B-K Medical as external validation site for a new biological process sought patent protected by B-K Medical
- has assisted AdvanDx regarding sequencing validation of bacterial strains
- has developed different molecular diagnostic methods for process control for Axellia
- has assisted LEO Pharma regarding characterization of a production strain
- has assisted SMB with process development within antibody modification and purification
- Bioneer has assisted Rose Pharma on receptor binding studies
- Bioneer has assisted the Ministry of Food, Agriculture and Fisheries (Ministeriet for Fødevarer, landbrug og fiskeri) with consultancy and laboratory analysis
- Bioneer has assisted the Ministry of The Environment (Miljøministeriet) with consultancy and laboratory analysis
